% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{:885928,
      author       = {Ю. Скворцова, T. and Judov, Natalie and Plotkin,
                      M. and Stoffels, Gabriele and Galldiks, Norbert and
                      Красикова, Р. Н. and Langen, Karl-Josef},
      title        = {{T}he {R}ole of {R}adionuclide {D}iagnostic {M}ethods in
                      {N}euro-{O}ncology},
      journal      = {Vestnik rentgenologii i radiologii},
      volume       = {101},
      number       = {4},
      issn         = {0042-4676},
      address      = {Moskva [u.a.]},
      publisher    = {Medicina},
      reportid     = {FZJ-2020-04184},
      pages        = {221 - 234},
      year         = {2020},
      abstract     = {In recent years, positron emission tomography (PET) with
                      amino acid radiopharmaceuticals has assumed increasing
                      importance in the diagnosis of brain tumors and it has
                      already become an additional method of examination along
                      with magnetic resonance imaging (MRI) in many diagnostic
                      centers. The markers of somatostatin receptors seem to be
                      most promising for the PET diagnosis of meningiomas. PET
                      provides important additional information in the diagnosis
                      of brain changes of unknown origin and more accurate
                      information about tumor boundaries, which is necessary for
                      biopsy, neurosurgery, and radiation therapy. In addition,
                      labeled amino acid PET aids in the assessment of disease
                      prognosis, in the differentiation of continued tumor growth
                      from nonspecific therapeutic pathomorphism of the brain, and
                      in the evaluation of treatment efficiency at an earlier time
                      than is possible with MRI.},
      cin          = {INM-4 / INM-3},
      ddc          = {610},
      cid          = {I:(DE-Juel1)INM-4-20090406 / I:(DE-Juel1)INM-3-20090406},
      pnm          = {573 - Neuroimaging (POF3-573)},
      pid          = {G:(DE-HGF)POF3-573},
      typ          = {PUB:(DE-HGF)16},
      doi          = {10.20862/0042-4676-2020-101-4-221-234},
      url          = {https://juser.fz-juelich.de/record/885928},
}